GE gets go-ahead for NT workstations

Article

GE gets go-ahead for NT workstationsThe Integrated Imaging Solutions division of GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations

GE gets go-ahead for NT workstations

The Integrated Imaging Solutions division of GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations (

PNN

4/98). The news is an important milestone for GE as the vendor seeks dominance in a PACS market where NT-based solutions are increasingly in demand. Shipments are expected to begin in the fourth quarter of this year.

In other GE news, the Milwaukee-based company has received a $1.3 million contract from Precedent Health Center in Denver that covers equipment and service agreements and includes three high-resolution workstations for diagnostic reading. Four clinical review workstations will be placed in multiple departments. Ultrasound, CT, MRI, fluoroscopy, CR, and nuclear medicine will be hooked to the PACS, and two film digitizers will be installed.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.